Half my family has the disease,” says Adam Jardine, who works as a congressional staffer. “I try to stay positive throughout ...

While a repeat kidney biopsy did not reveal findings diagnostic of Alport syndrome, genetic testing demonstrated a heterozygous mutation in COL4A5, which confirmed the diagnosis of X-linked Alport ...

AIM/BACKGROUND Alport syndrome is an X linked disease that results in renal failure, deafness, and ocular abnormalities including a dot and fleck retinopathy and anterior lenticonus. The ...

A 44-year-old Caucasian man with a history of deceased donor renal transplant for end-stage renal disease from Alport’s syndrome (AS), presented with a spontaneous subarachnoid haemorrhage and ...

These deletions were compared to that found in a fifth patient diagnosed with ATS-DL contiguous gene syndrome, whose deletion extends beyond COL4A5 towards the centromere. The family of proband 850 ...

The Alport Syndrome drugs in development market research report provides comprehensive information on the therapeutics under development for Alport Syndrome, complete with analysis by stage of ...

unimelb.edu.au Background and aims: Alport syndrome is an inherited disease with renal failure, and often a hearing loss, lenticonus and dot-and-fleck retinopathy. A retinal “lozenge” or “dull macular ...

New Manchester hub launched to accelerate treatment and awareness for Alport syndrome Partnership with Kidney Research UK and a £2.55 million investment from the Stoneygate Trust aims to deliver a ...

Canaccord Genuity analyst Whitney Ijem has maintained their bullish stance on RGLS stock, giving a Buy rating yesterday. Whitney Ijem has ...

RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I ...